Pluri, Inc. ('Pluri”, the 'Company”, 'we” or 'us”) (Nasdaq, TASE: PLUR), a biotechnology company leveraging its proprietary platform for cell-based solutions through a collaborative network of ...
Galderma to showcase the latest scientific advances behind the industry’s broadest injectable aesthetics portfolio at IMCAS 2026: Zug, Switzerland Friday, January 23, 2026, 12:0 ...
Pluri, Inc. ("Pluri", the "Company", "we" or "us") (Nasdaq, TASE: PLUR), a biotechnology company leveraging its proprietary platform for cell-based solutions ...
New year, new beauty routine.
Forever chemicals' could cost Europe up to €1.7 tn by 2050: report Galderma (SIX: GALD) will present ten posters with the latest updates from across its broad aesthetic portfolio spanning regenerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results